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Abstract
Background: Cathepsin cysteine proteases play multiple roles in the life cycle of parasites such as food uptake,
immune invasion and pathogenesis, making them valuable targets for diagnostic assays, vaccines and drugs. The
purpose of this study was to identify a cathepsin B of Clonorchis sinensis (CsCB) and to investigate its diagnostic
value for human helminthiases.
Results: The predicted amino acid sequence of the cathepsin B of C. sinensis shared 63%, 52%, 50% identity with
that of Schistosoma japonicum, Homo sapiens and Fasciola hepatica, respectively. Sequence encoding proenzyme of
CsCB was overexpressed in Escherichia coli. Reverse transcription PCR experiments revealed that CsCB transcribed in
both adult worm and metacercaria of C. sinensis. CsCB was identified as a C. sinensis excretory/secretory product by
immunoblot assay, which was consistent with immunohistochemical localization showing that CsCB was especially
expressed in the intestine of C. sinensis adults. Both ELISA and western blotting analysis showed recombinant CsCB
could react with human sera from clonorchiasis and other helminthiases.
Conclusions: Our findings revealed that secreted CsCB may play an important role in the biology of C. sinensis
and could be a diagnostic candidate for helminthiases.
Background
Clonorchis sinensis is the causative agent of clonorchia-
sis, a chronic liver infection of human acquired through
consumption of raw or undercooked fish and shrimps
with infectious metacercariae. Clonorchiasis is endemic
in Asian countries and over 35 million people globally
are infected C. sinensis, including an estimated 15 mil-
l i o ni nP e o p l e ’s Republic of China [1]. Recently, this
infection has emerged in non-endemic regions and
developed countries following growing international
markets, improved transportation systems and demo-
graphic changes such as population movements [2].
C. sinensis adults reside chronically in the biliary tract
and cause periductal inflammation, fibrosis, pyogenic
cholangitis, biliary calculi, cholecystitis, liver cirrhosis
and pancreatitis [3]. Like Opisthorchis viverrini, C. sinen-
sis is one of the direct causes of cholangiocarcinoma
announced by the International Agency for Research on
Cancer (IARC) in 2009 [4]. It is important to take some
measures to control clonorchiasis due to its public
health threat. Until now, the main prevention and con-
trol strategies for this parasite are treatment of indivi-
dual patients with praziquantel, and interrupting
transmission at the intermediate host level [5]. However,
there have been little effective measures to prevent this
neglected tropical disease [6].
Cysteine proteinase is ubiquitous in all species [7-9].
In parasites, cysteine proteases have attracted much
attention for their essential roles in parasite physiology
as well as in host-parasite interactions through their
modulation of various pathobiological events, including
host tissue invasion, nutrient uptake, host immune
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ducted to characterize the biochemical properties and
pathophysiological roles of cysteine proteases from
trematode parasites. The essential roles of cysteine pro-
teases in parasite survival or growth make them attrac-
tive targets for vaccines or chemotherapeutic agents
[14-16]. Several genes encoding C. sinensis cysteine pro-
teases have been identified and partially characterized
[17-19]. Lee et al. [20] reported that cathepsin F-like
cysteine protease of C. sinensis is a good vaccine candi-
date against clonorchiasis. Li et al. [21] found that endo-
genous cysteine proteases of C. sinensis metacercariae
are probably involved in the excystment process. Kang
et al. [22] indicated that partially purified cysteine pro-
tease from excretory/secretory products (ESP) of
C. sinensis adults exhibited significant cytotoxic effects
against cultured cells. ESP of parasites have attracted
more attention for their significant roles in the diagno-
sis, vaccine, drug target and host-parasite interactions
etc. In vitro biochemical studies have predicted that ESP
from liver flukes have definitive roles in feeding beha-
vior, detoxification of bile components and immune
evasion [23]. Ju et al. [18] have identified legumain from
ESP as a serodiagnostic antigen of clonorchiasis. In
addition, several genes encoding C. sinensis cysteine pro-
teases have also been identified and their value as diag-
nostic antigens for clonorchiasis was investigated
[24,25]. However, little is known about cathepsin B (CB)
in C. sinensis except five distinct sequences deposited in
Genbank.
As members of the cysteine protease family, cathe-
psins have been assayed in the serodiagnosis of both
human and animal in parasite infections. Cornelissen et
al. [26] reported a specificity of 75.3% in naturally
infected cattle using Fasciola hepatica cathepsin L as
coating antigen. Carnevale et al. [27] found that recom-
binant pro-cathepsin-L was 100% specific in the diagno-
sis of human F. hepatica infection. Sripa et al. [28]
indicated that Ov-CB-1 was acceptable in ELISA for the
serodiagnosis of human opisthorchiasis with 67% and
81% of sensitivity and specificity, respectively. To find
out whether CB could be applied for serodiagnosis in
C. sinensis infection, we identified a gene encoding
cathepsin B of C. sinensis (CsCB) and investigated its
diagnostic value for human helminthiases.
Results
Sequence analysis of CsCB gene sequence
The complete coding sequence of CsCB is comprised of
1,020 bp encoding a putative protein of 339 amino acids
with a predicted molecular mass of 37.9 kDa and an iso-
electric point of 5.32. The ORF consists of a hydropho-
bic signal peptide at the N-terminus, followed by a pro-
region of between 70 and 71 AA and a mature protease
sequence. BLASTx showed that it shared 63%, 52%, 50%
and 53% identity with CB of Schistosoma japonicum,
Homo sapiens, F. hepatica and Echinococcus multilocu-
laris, respectively. Highly conserved residues of the cata-
lytic triad (Cys116,H i s 285 and Asn305)a sw e l la st h eG l n
could be searched in this sequence. The putative protein
contained an occluding loop that is the signature of
cathepsin Bs and a haemoglobinase motif which is
shared by helminth blood-feeders (Figure 1).
Cloning, expression and purification of recombinant CsCB
(rCsCB) in E. coli
The recombinant pET-28a(+) plasmid containing the CB
gene coding region (signal peptide removed) was con-
firmed by digestion with restriction enzyme. DNA sequen-
cing revealed that the construct was correct with 6 × His
tag at the N terminus of the recombinant protein. The
recombinant CsCB was expressed in inclusion bodies in
E. coli. SDS-PAGE showed that the molecular mass of
fusion protein was about 40 kDa, which was in correspon-
dence with the predicted 39.2 kDa (including 34 amino
acids of vectors). After purification and renaturation, the
concentration of the recombinant protein was about
0.25 mg/ml (Figure 2A).
Identification of CsCB as ESP by western blotting
Rat anti-rCsCB antibody titers were higher than 1:102,400
as determined by ELISA. In western blotting assay, both
C. sinensis-infected rat serum and anti-CsCB rat serum
could react with the CsCB while the normal rat serum
could not. Comparing with the control group, sera from
rats immunized with total ESP could recognize CsCB. In
addition, ESP has been shown to react with anti-CsCB rat
serum (data not shown). The results above indicated that
CsCB was a component of ESP (Figure 2B).
RT-PCR analysis of CsCB at life-stage of C.sinensis
CsCB transcrips were detected both in adults and meta-
cercaria of C. sinensis ( F i g u r e3 A ) ,a n dt h ee x p r e s s i o n
level in adults was higher than that of metacercaria
when normalized by b-actin (Figure 3B, P < 0.05).
Immunohistochemical localization of CsCB in C. sinensis
adults
Using the antisera against CsCB as the primary antibody
and fluorescence labeling IgG as the secondary antibody,
immunolocalization showed that CsCB distributed in the
intestine of adults, while no specific fluorescence except
autofluorescence was detected in adults treated with
normal serum (Figure 4).
Serodiagnosis of human helminthiases
The optimal concentration of coating antigen and dilu-
tion of serum samples determined by checker board
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off value for positive infection status in ELISA tests eval-
uated by receiver operating characteristic (ROC) curve
was 0.47 (Figure 5). Sera from humans infected with
C. sinensis showed a sensitivity of 79% by ELSA based
on rCsCB and healthy sera and sera from those infected
with other helminths showed a specificity of 81%
(Table 1). Both ELISA and western blotting assays
showed that rCsCB could react with human sera from
clonorchiasis, fascioliasis, schistosomiasis, paragonimia-
sis, cysticercosis and echinococciosis (Figure 6).
Discussion
Cathepsins in general are of interest to parasitologists, as
there is considerable evidence that they play a key role in
the biology of parasites [29]. In this study, a CB of
C. sinensis was cloned and overexpressed in E. coli. It was
classified as CB due to its sequence homology to cathe-
psin B protein and structure. The putative amino acid
sequence shared 63%, 52% and 50% identities with cathe-
psin B from S. japonicum, H. sapiens and F. hepatica,
respectively. Sequence analysis showed that CsCB has
typical catalytic residue of cysteine, histidine and aspara-
gine, as well an occluding loop that is the signature of
cathepsin Bs [30]. A haemoglobinase motif which is
shared by helminth blood-feeders could be found in this
deduced sequence [31]. Since C. sinensis generally feed
on bile and epithelial cells rather than blood, however, it
is thought that this motif may be an important tool for
identifying potential hemoglobinases and contribute to
haemoglobin degradation [32]. The occluding loop is a
distinctive feature of CBs; it is not only responsible for
exopeptidase activity to CBs, but also governing the pH
dependence of auto-activation. In F. hepatica, Beckham
[33] reported that recombinant FhCatB1 did not auto-
activate upon secretion by yeast but could be auto-
activated in a low pH buffer. As it stands, CsCB may
develop auto-activation in an appropriate pH buffer, so
further studies will be carried out to investigate the auto-
activation and enzyme activity of this protease.
Cathepsin B proteases of parasitic helminths such as
F. hepatica and Schistosoma mansoni have been well stu-
died. In F. hepatica, for example, there are at least 10
genes encoding CB being identified by using proteomics
and transcriptome analysis, among which six are compo-
nents of ESP of immature flukes. RNAi directed to
FhCB2 reduced invasion of F. hepatica newly excysted
juveniles through the intestine in vitro and vaccine with
F. hepatica CB2 reduced fluke burdens and liver damage
in rats following challenge, revealing that FhCB2 was a
Figure 1 Alignment of cathepsin B (CsCB) deduced amino acid sequence from C. sinensis and other species. The deduced amino acid
sequence shares 63%, 52%, 50% and 53% identity with CB of S. japonicum, H. sapiens, F. hepatica and E. multilocularis, respectively. Highly
conserved residues are shaded in gray. Residues of the catalytic triad (Cys116, His285 and Asn305) are indicated with black triangles. The oxyanion
Gln is marked with white triangle; arrow shows cleavage point of mature enzyme, the occluding residues and hemoglobinase motif are boxed.
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[34]. In S. mansoni, SmCB1 and SmCB2 have been identi-
fied and the function of SmCB1 was examined using
RNAi silencing, which illustrated that SmCB1 played a
role in nutrient acquisition [35,36]. Based on the key role
of CB in the biology of parasites, we expect that CsCB
may play the same role in nutrition intake and immune
invasion of host. In multicellular parasites such as
trematodes, the intestine is a major source of secreted
proteases and also a place for nutrition digestion and
absorption. According to results of immunolocalization,
CsCB was distributed in the intestine of adult worm,
indicating that CsC Bm i g h tb ei n v o l v e di nd i g e s t i o no f
host protein and nutrient uptake for this parasite itself.
In our RT-PCR experiments, CsCB could be detected in
both adult worm and metacercaria of C. sinensis.A sa
Figure 2 Expression, purification and identification of CsCB. A. Expression and purification of CsCB by 12% SDS-PAGE. M, protein molecular
weight markers; lane 1, lysate of E. coli with pET-28a(+) without IPTG induction; lane 2, lysate of E. coli with pET-28a(+) with IPTG induction, lane
3, lysate of E. coli with pET28a(+)-CsCB before induction; lane 4, lysate of E. coli with pET28a(+)-CsCB after induction; lane 5, supernatant of
induced pET28a(+)-CsCB; lane 6, sediment of induced pET28a(+)-CsCB; lane 7, purified CsCB. B. Western blotting analysis of recombinant CsCB.
Lane 1, recombinant CsCB reacted with the sera from normal rats; lane 2, recombinant CsCB reacted with the sera from rats immunized with
recombinant CsCB; lane 3, recombinant CsCB reacted with the sera from C. sinensis-infected rats; lane 4, recombinant CsCB reacted with the sera
from rats immunized with the ESP.
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CsCB may play an important role in the biology of this
parasite.
Proteases contained in ESP of parasites released to the
environment, play key roles in bile duct malignancy and
the subsequent development of cholangiocarcinoma
[37,38]. Our previous studies revealed that ESP of adult
C. sinensis lysophospholipase and phospholipase A2
might be pathogenic factors of human hepatic fibrosis
caused by infection of C. sinensis [39,40], which could
deepen our understanding of the pathogenesis of C.
sinensis. CB has already been found in ESP of C. sinensis
and some other helminths [41]. Moreover, western blot-
ting revealed that CsCB was a component of ESP, and
CsCB could react with C. sinensis-infected rat serum.
In ELISA results, rats injected with recombinant CsCB
developed high antibody titers. Our results showed
that CsC Bm i g h tb ei n v o l v e di nt h ep a t h o g e n e s i so f
C. sinensis-related hepatobiliary diseases as a component
of ESP with antigenicity and immunogenicity. Indeed,
Figure 3 Transcriptional level of C. sinensis CB at metacercaria and adult worm.A . 1% agarose gel. DNA marker (M), CsCB PCR products
amplified from adult worm cDNA (lane 1), metacercaria cDNA (lane 2), b-actin amplified from adult worm cDNA (lane 3), metacercaria cDNA
(lane 4) and CsCB PCR product amplified from recombinant CB plasmid (lane 5). B. PCR products were quantified and analyzed. PCR products
were quantified by Tanon Gis software, compared normalized by C. sinensis b-actin, analyzed by Student’s t test (Software package SPSS16.0). P-
value of < 0.05 indicated statistical significance.
Figure 4 Immunolocalization of CsCB in adult worm of C. sinensis. Rat anti-CsCB serum was used as primary antibody and goat anti-rat IgG
as the secondary antibody. Panel A and D show tissues of adult worm under fluorescence microscope. Panel A and C show the same part
under white light. Panel A and B were the negative control treated with preimmune rat serum. i, intestine s, sucker. The images were magnified
at 100× for photograph.
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tently released ESP resulting in mechanical damage and
chemical stimulus which must have brought on infiltra-
tion of inflammatory cells surrounding bile ducts and
adenomatous hyperplasia of biliary epithelia [42-44].
However, there remains much to do to elucidate the
mechanism of C. sinensis causing hepatobiliary diseases.
We have also approached the antigenicity and diagnostic
value of CsCB in human helminthiases. Both the ELISA
and western blotting showed that CsCB could react with
sera from most of human helminthiases, but not with
sera from healthy people. High identity in the predicted
amino acid sequences of C. sinensis and other helminths
could be responsible for the observed cross-reactivity.
Though cross-reactivity existed, CsCB could also be
applied as a diagnostic candidate of clonorchiasis since
treatment with praziquantel has the same efficacy on
helminths.
Conclusion
A gene encoding cathepsin B protein of adult C. sinensis
was cloned and expressed for the first time. Our find-
ings revealed that CsCB, which is expressed in the intes-
tine and released outside the worm as a component of
ESP, may play an important role in the biology of
C. sinensis. Moreover, CB may play conserved roles in
helminths for the high homology analyzed by bioinfor-
matics. Further investigations are required to character-
ize the conserved functions of such important protease
and the role as a potential vaccine candidate against
C. sinensis infection.
Materials and methods
Sequence analysis of CsCB gene sequence
A complete coding sequence encoding CB was isolated
from GenBank (Accession no. EF102086.1) in NCBI
http://www.ncbi.nlm.nih.gov/, the physicochemical
properties and the functional domains in deduced
amino acids were predicted by proteomics tools in
ExPaSy web site http://www.expasy.org/. Based on the
similarity, the homologous sequences of different
species, including E. multilocularis (BAJ83491.1),
F. hepatica(ABU62925.1), S. japonicum (CAX71086.1),
H. sapiens (NP_001899.1), Paragonimus westermani
(AAB93494.1) and Taenia solium (AAS00027.1) were
identified using the basic local alignment search tool
(BLAST) server. Multiple sequences alignments were
performed using bioinformatics analysis software
Vector NTI suite 8.0.
Cloning, expression, purification and refolding of CsCB in
E. coli
Gene sequence encoding CsCB (signal peptide excluded)
was amplified from cDNA of C. sinensis by polymerase
Figure 5 ROC analysis of performance of rCsCB as a
serodiagnostic antigen. ROC curve of rCsCB employed as the
antigen in ELISA, calculated from OD450 values of sera from
parasitologically positive and negative clonorchiasis individuals. The
curve was plotted between sensitivity and 1-specificity for different
cut-off values of OD450. The curve showed that the optimal cut-off
value at OD450 was 0.47 with the area under curve (AUC) was 0.84.
Table 1 Summary of difference between rCsCB ELISA and
stool examinations results.
Panel A
CsCB ELISA No. of samples from stool examination
Negative Positive Total
Negative 158(81%) 17 175
Positive 38 63(79%) 101
Total 196 80 276
Panel B
Parasites No. of serum
samples





Fasciola hepatica 42 15(36%)
Schistosoma japonicum 41 13(32%)
Paragonimus westermani 21 4(19%)
Taenia solium 20 2(10%)
negative 50 1(2%)
Total 196 38(19%)
Panel A: Comparison of the rCsCB ELISA with microscopic examination of stool
samples as the gold standard method for diagnosis of clonorchiasis in 276
human sera. rCsCB ELISA test showed 81% specificity and 79% sensitivity with
reference to stool examination. Panel B: Number of the sera from individuals
infected with other helminths used for cross-reactivity tests.
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GGATCCGAGTATATTCCATCTTTCGA-3’ and the
reverse primer: 5’-GTCCTCGAGTCACAGTTTTG-
GATGACC-3’ with BamHI/XhoI restriction enzyme
sites (underlined). PCR was carried out for 30 cycles at
94°C for 45 s, 57°C for 45 s, and 72°C for 60 s, and the
reaction continued for 10 min at 72°C after the last
cycle. Purified PCR products were cloned into the His6
tag expression vector pET-28a(+) (Novagen; USA) with
corresponding incision enzymes. The recombinant plas-
mid was transformed into E. coli for expression and
insertion confirmed by digestion with restriction enzyme
and DNA sequencing. Expression of recombinant CsCB
protein was induced by isopropyl-b-D-thiogalactoside
(IPTG) at a final concentration of 0.2 mM for 3 h at
30°C. The bacterial cells were collected by centrifugation
at 4°C, and the inclusion bodies containing the recombi-
nant fusion protein were solubilized completely with
6 M urea in 20 mM Tris-HCl buffer (pH 8.0), followed
by purification with His Bind Purification kit (Novagen;
USA) and elution with 150 mM imidazole. Renaturation
was carried out by stepwise diluting urea in dialysate
buffer (20 mM Tris-HCl, 5 mM EDTA buffer, pH 8.0).
Purified protein was analyzed by sodium dodecyl sul-
fate-polyacrylamide gel electrophoresis (SDS-PAGE) and
stained with Coomassie blue, final recombinant protein
concentration was estimated by Bradford assay using
BSA method used as a standard.
Semi-quantitative reverse transcription-PCR (RT-PCR)
analysis of CsCB
In order to determine the mRNA transcriptional level of
CsCB in various stages of the parasite, total RNA of adult
worms and metacercariae were extracted and quantitated
by nucleic acid/protein analyzer (Beckman Coulter; USA).
Reverse transcription reactions were carried out by trans-
forming equal amounts of total RNA (1 μge a c h )t oc D N A
using RT-PCR Kit (TaKaRa; PR China). RT-PCR experi-
ments were employed to amplify the transcripts of CsCB
from cDNA of adult worms and metacercariae, respec-
tively, and C. sinensis b-actin (GenBank accession no.
EU109284) was used as a positive control. The forward
and reverse primer for CsCB were 5’-GGATTCGGCCTG-
GAAAAAC-3’,5 ’-CAGTTTTGGATGACCAGCAT-3’
and for b-actin were 5’-GGTGACGCTGAAGTATCC-
TATTGA-3’,5 ’-CCAAAGCATAGCCCTCGTAGAT-3’,
respectively. The programs for PCR were the same as
described above. PCR products from two life stages were
quantified by Tanon Gis software (Tanon 4100; PR China)
normalized by C. sinensis b-actin and analyzed by
Figure 6 Immune response to human helminthiases of rCsCB. 1-7: clonorchiasis, fascioliasis, schistosomiasis, paragonimiasis, echinococciosis,
cysticercosis and healthy serum, respectively. A. Serodiagnosis of human helminthiases by ELISA(scatter plot). B. Immune reactionsshown by
western blotting. The probed bands were indicated with arrow.
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0.05 indicated statistical significance.
Preparation for the antisera of recombinant protein and
C. sinensis excretory/secretory product (ESP)
Living adults of C. sinensis were collected and cultured
in RPMI-1640 (Gibco; USA) at 37°C under 5% CO2 for
6 h. The culture was centrifuged at 12,000× g at 4°C for
30 min to remove insoluble debris. The supernatant was
dialyzed in PBS for 12 h and concentrated with sucrose.
Six-week-old male Sprague-Dawley rats were purchased
f o ra n i m a le x p e r i m e n t su n d e rt h eG u i d ef o rt h eC a r e
and Use of Laboratory Animals. Both the recombinant
CB and ESP were emulsified with complete Freund’s
adjuvant and immunized subcutaneously to SD rats.
Each rat was given 200 μgr CsCB or ESP at the first
injection, and 100 μg protein (emulsified with incom-
plete Freund’s adjuvant) was given for 2 booster injec-
tions at 2-week intervals; antisera were collected before
each injection and serum antibody responses to rCsCB
and ESP were tested by ELISA.
SDS-PAGE and western blotting
The recombinant protein (1 μg per lane) was subjected
to SDS-PAGE and electrotransferred onto polyvinylidene
difluoride membrane (PVDF, Whatman; USA) at 100 v
for 1 h. The membrane was blocked with 5% skim milk
in phosphate buffered saline tween-20 (PBST, pH 7.4) at
37°C for 2 h, washed 5 times with PBST, then incubated
with different antisera (antisera against the recombinant
CsCB protein, antisera against the ESP, sera from
C. sinensis-infected rats and normal rats, respectively,
1 : 2 0 0d i l u t i o n sf o ra l ls e r a )a t3 7 ° Cf o r2h .A f t e rw a s h -
ing, the membrane was incubated with rabbit anti-rat
IgG HRP-conjugated horse radish peroxidase (1:2,000
dilution; Boster; PR China) at 37°C for 1 h. Diaminoben-
zidine (DAB) substrate solution (Invitrogen, USA) was
used to visualize the reaction according to the manufac-
turer’s instructions.
Immunolocalization of CsCB protein in C. sinensis adult
worm
C. sinensis adult worms fixed with 10% neutral formalin
were embedded with paraffin and sliced into 3-5 μm
thickness. After deparaffinating with dimethyl benzene
and gradient alcohol, all sections were blocked with nor-
mal goat serum at 4°C overnight, then incubated with
rat anti-CsCB serum for 2 h at room temperature (RT),
the sera from normal rats were used as negative control,
the serum was diluted at 1: 200 for all sections. The sec-
tions were subsequently incubated with goat anti-rat
IgG labeled with red-fluorescent Cy3 (1: 400 dilutions
with 0.1% BSA in PBS, Jackson, USA) for 1 h at RT in
dark and imaged using fluorescent microscope (ZEISS;
Germany).
Source of serum samples
A total of 276 human serum samples were employed in
order to approach the antigenicity and diagnostic value
of CsCB in human helminthiases. 80 sera from clo-
norchiasis patients were collected from endemic areas in
Guangxi Province and were egg-positive proved by
microscopic examination of stool samples. Other human
sera including single infection of E. multilocularis (22),
F. hepatica (42), S. japonicum (41), P. westermani (21),
T. solium (20) and 50 samples of serum from healthy
humans were provided and diagnosed by Centers for
Disease Control and Prevention of Nanning, Jiangsu,
Gansu and Fujian provinces. Sera were retrieved and
stored in aliquots at -20°C until use.
Serodiagnosis of human helminthiases by ELISA and
western blotting
The optimal antigen concentration and serum dilution
required for ELISA were determined by checker board
titration. Briefly, 96-well microtiter plates (Costar, USA)
were coated with 100 μl1μg/ml, 3 μg/ml, 5 μg/ml,
7 μg/ml rCsCB (in 0.05 mol/l NaHCO3 buffer, pH 9.6)
and incubated at 4°C overnight. After three washings
with PBST, the microplates were blocked with 5%
skimmed milk (w/v,i nP B S Tc o n t a i n i n g0 . 1 %B S A )f o r
2 h at 37°C. Following another washing procedure, the
plates were incubated with human helminthiases sera
(1:50, 1:100, 1:200, 1:400 dilutions for each coating con-
centration in PBST containing 0.1% BSA) for 2 h at
37°C. Goat anti-human IgG (1:10,000 dilutions in 0.1%
BSA-PBST recommended by producer; Invitrogen, USA)
were employed as the secondary antibody. Subsequent
reactions were developed with 3’,3 ’,5 ’,5 ’-tetramethyl
benzidine (TMB; BD Biosciences; USA) and stopped
with 2 M H2SO4. All assays were tested in triplicate and
repeated twice. The absorbance value was measured at
450 nm.
In western blotting assay, rCsCB was subjected to 12%
SDS-PAGE and electrotransferred onto PVDF mem-
brane (Whatman; USA). The membrane was incubated
with different human helminthiases sera (clonorchiasis,
echinococciosis, fascioliasis, schistosomiasis, paragoni-
miasis, and cysticercosis, respectively) which showed
high OD450 values by ELISA test at 37°C for 2 h, human
healthy serum was used as negative control, all sera
were 1:400 diluted in PBST containing 0.1% BSA. Goat
anti-human IgG HRP-conjugated horse radish peroxi-
dase (1:2,000 dilution; Boster; PR China) was the sec-
ondary antibody to react with the membrane and DAB
substrate solution was used to visualize the reaction.
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Software package SPSS16.0 was used in the present
study for all statistical analysis. Briefly, Student’s t test
was used to analyze the measurement data among
groups. P value of < 0.05 was considered statistically sig-
nificant. The optimal cut-off value was calculated based
on ROC curve analysis which correlated with sensitivity
and 1-specificity [45]. ROC curve, area under the curve
(AUC) and scatter plot were carried out using SPSS16.0.
The sensitivity and specificity were calculated using
microscopic examination of stool samples as gold stan-
dard method.
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